Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
2.720
-0.870 (-24.23%)
May 13, 2025, 3:13 PM - Market open
Cyclacel Pharmaceuticals Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$11.00
Upside
+304.41%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $21 → $11 | Strong Buy | Maintains | $21 → $11 | +304.41% | May 3, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 19, 2023 |
| Roth MKM | Roth MKM | Strong Buy Maintains $16 → $21 | Strong Buy | Maintains | $16 → $21 | +672.06% | Dec 19, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $120 | Buy | Maintains | $120 | +4,311.76% | May 25, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $150 → $120 | Buy | Maintains | $150 → $120 | +4,311.76% | Mar 7, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $255 | Buy | Initiates | $255 | +9,275.00% | Jul 18, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $255 | Buy | Initiates | $255 | +9,275.00% | Apr 30, 2021 |